Tytuł pozycji:
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157.
-
Tytuł:
-
Re: Does the Visibility of Grade Group 1 Prostate Cancer on Baseline Multiparametric Magnetic Resonance Imaging Impact Clinical Outcomes?D. Deniffel, E. Salinas, M. Ientilucci, A. J. Evans, N. Fleshner, S. Ghai, R. Hamilton, A. Roberts, A. Toi, T. van der Kwast, A. Zlotta, A. Finelli, M. A. Haider and N. Perlis J Urol 2020; doi: 10.1097/JU.0000000000001157.
-
Autorzy:
-
Stavrinides V; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Giganti F; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Punwani S; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Allen C; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Kirkham A; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Freeman A; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Ball R; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Haider A; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Whitaker H; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Orczyk C; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Emberton M; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
Moore CM; Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Department of Radiology, Department of Pathology, University College London Hospital NHS Foundation Trust, London, United Kingdom.; The Alan Turing Institute, London, United Kingdom.
-
Źródło:
-
The Journal of urology [J Urol] 2020 Nov; Vol. 204 (5), pp. 1065-1066. Date of Electronic Publication: 2020 Jul 23.
-
Typ publikacji:
-
Letter; Comment
-
Język:
-
English
-
Imprint Name(s):
-
Publication: 2019- : [Philadelphia, PA] : Wolters Kluwer
Original Publication: Baltimore : Lippincott Williams & Wilkins
-
MeSH Terms:
-
Multiparametric Magnetic Resonance Imaging*
Prostatic Neoplasms*/diagnostic imaging
Humans ; Male ; Neoplasm Grading
-
Grant Information:
-
MR/S005897/1 United Kingdom MRC_ Medical Research Council
-
Entry Date(s):
-
Date Created: 20200724 Date Completed: 20201104 Latest Revision: 20210310
-
Update Code:
-
20240104
-
DOI:
-
10.1097/JU.0000000000001295
-
PMID:
-
32698715
-
Comment on: J Urol. 2020 Jun 4;:101097JU0000000000001157. (PMID: 32496160)
Comment in: J Urol. 2020 Nov;204(5):1066-1067. (PMID: 32698718)
